These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 5005649)

  • 21. [Prevention of post-transfusional feto-maternal immunizations].
    Caderas De Kerleau J; Durand C
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):230. PubMed ID: 4220062
    [No Abstract]   [Full Text] [Related]  

  • 22. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 23. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the effectiveness of anti Rh gamma globulin].
    García Roel R; Santos Martínez A; Salgado Alcocer N
    Ginecol Obstet Mex; 1974 Jan; 35(207):67-73. PubMed ID: 4133289
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of feto-maternal isoimmunizations. Organization in the Marseilles region].
    Nublat M; Dufour Y; Gaujoux J; Alcaraz J; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):209-11. PubMed ID: 4143444
    [No Abstract]   [Full Text] [Related]  

  • 26. [New information about the prevention of Rh isoimmunization].
    Tesauro G
    Minerva Ginecol; 1968 May; 20(10):847-50. PubMed ID: 4186920
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 28. [Systematic immunization in pregnancy].
    Simonetti N
    Minerva Ginecol; 1972 Feb; 24(2):98-9. PubMed ID: 4211684
    [No Abstract]   [Full Text] [Related]  

  • 29. [Partial replacement of blood transfusions as a method of reducing RH-sensitization in obstetrical practice].
    Vasil'eva ZF; Matveeva OF; Kuznechikova VV; Anichkova SI
    Vopr Okhr Materin Det; 1971 Oct; 16(10):64-7. PubMed ID: 5001887
    [No Abstract]   [Full Text] [Related]  

  • 30. [Letter: Prevention of Rh sensitization].
    Schneider J
    Dtsch Med Wochenschr; 1976 Apr; 101(15):596. PubMed ID: 816630
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunosuppression of anti-Rh antibodies: mechanism of action and times of administration of the anti-D immunoglobulins].
    Carretti N
    Attual Ostet Ginecol; 1968; 1():181-92. PubMed ID: 4194920
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of immunoprophylaxis in negative Rhesus factor].
    Kotzbach R; Kłyszejko C; Sobociński Z; Włodarczyk L; Kotzbach M
    Ginekol Pol; 2000 Aug; 71(8):859-62. PubMed ID: 11082937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of anti-Rh immunoglobulin in the prevention of isoimmunization to Rh factor].
    Medina Aguilar R
    Ginecol Obstet Mex; 1969 Jul; 26(153):47-59. PubMed ID: 4185870
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of anti-CD gamma globulin in the prevention of materno-fetal isoimmunization].
    Crespo Cortina M; Arroyo Bornstein A; Olivares Tinajero G
    Ginecol Obstet Mex; 1972 Jan; 31(183):75-81. PubMed ID: 4109103
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies].
    Schneider J
    Z Geburtshilfe Perinatol; 1972 Feb; 176(1):2-16. PubMed ID: 4553933
    [No Abstract]   [Full Text] [Related]  

  • 36. Rho (D) immune prophylaxis. A double-blind cooperative study.
    White CA; Visscher RD; Visscher HC; Wade ME
    Obstet Gynecol; 1970 Sep; 36(3):341-6. PubMed ID: 4988961
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current status of the use of immunosuppressive agents based on hyperimmune gamma globulins].
    Crespo Cortina M; Arroyo Bornstein A
    Ginecol Obstet Mex; 1972 Apr; 31(186):369-73. PubMed ID: 4112876
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current status of prevention of Rh-isoimmunization at the Obstetric and Gynecological Clinic of the University of Naples].
    Paladini A; Rascio B; Di Lieto A; Tinelli FG
    Arch Ostet Ginecol; 1970; 75(5):367-74. PubMed ID: 5003501
    [No Abstract]   [Full Text] [Related]  

  • 39. [Critical study of the results of an application of preventive treatment taking into account the systematic evaluation of feto-maternal hemorrhage].
    Huchet J; Crégut R; Briffoteaux P; Pinon F
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):203-5. PubMed ID: 4143442
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rhesus isoimmunization caused by a transfusion error].
    Van Kets HE; Derom R
    Bull Soc R Belge Gynecol Obstet; 1965; 35(3):205-7. PubMed ID: 4954904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.